Literature DB >> 12609445

Right Hemisphere Language Dominance in a Right-Handed Patient with Late-Onset Seizures.

Dana Boatman, Moona Alidoost, Gregory Bergey, Barry Gordon, Nathan Crone, John Hart, Frederick Lenz.   

Abstract

Right hemisphere language dominance is rare in right-handed individuals and usually the result of language transfer associated with early left hemisphere pathology. We studied a 33-year-old right-handed man, with a normal MRI scan, who developed left frontal lobe seizures at age 15 years. Language lateralization testing by intracarotid amobarbital injection and dichotic listening showed the patient to be strongly right hemisphere language dominant. The clinical features of this patient do not fit the profile of pathology-induced language transfer, but instead suggest that he was right hemisphere language dominant before developing seizures. This case underscores the importance of language lateralization testing in patients who are candidates for seizure surgery, even if they are strongly right-handed and have late-onset seizures, features usually associated with left hemisphere language dominance. One implication is that the incidence of right hemisphere language dominance in the right-handed population may be underestimated.

Entities:  

Year:  2000        PMID: 12609445     DOI: 10.1006/ebeh.2000.0079

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  Analysis of synchrony demonstrates that the presence of "pain networks" prior to a noxious stimulus can enable the perception of pain in response to that stimulus.

Authors:  S Ohara; N E Crone; N Weiss; J H Kim; F A Lenz
Journal:  Exp Brain Res       Date:  2008-01-30       Impact factor: 1.972

2.  Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus.

Authors:  Utku Uysal; Patrick Landazuri; Caleb Pearson; Manoj Mittal; Nancy Hammond
Journal:  Case Rep Neurol       Date:  2017-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.